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Abstract Aliphatic glucosinolates are a major class
of defensive secondary metabolites in plants that are
mostly derived from methionine. Occurring in dif-
ferent chain lengths, they show a structural diversity
arising from the variable number of chain elongation
cycles taking place during their biosynthesis. The key
enzymes in determining glucosinolate chain length
are the methylthioalkylmalate (MAM) synthases,
MAM1 and MAM3, with MAM3 showing a broader
substrate specificity than MAM1. A comparison of
the measurements of wild type and MAM1 knockout
mutant plants shows the following distinct changes in
glucosinolate chain length profiles:
(1) a reversal of the relative proportions of the two
shortest glucosinolates,
(2) a significant increase in the concentration of the
longest glucosinolate,
(3) an increase in total glucosinolate content in the
mutant.
MAM3 knockout mutants on the contrary differ
from wild type plants by a pronounced abundance of
the second shortest glucosinolate and the depletion
of the two longest glucosinolates. To clarify the
contribution of the multifunctional enzymes MAM1
and MAM3 to the glucosinolate profile of Arabid-
opsis thaliana leaves, we simulated glucosinolate
biosynthesis in a kinetic model, taking into account
the structure of the pathway and measured enzy-
matic properties. The predicted glucosinolate
profiles show all characteristics of the actual differ-
ences between wild-type and MAM1 mutants or
MAM3 mutants, respectively. The model strongly
supports experimental indications that the two MAM
activities are not independent of each other. In
particular, it showed that an elevated expression of
MAM3 in the MAM1 mutant is critical in deter-
mining the glucosinolate profile of this plant line.
The simulation was critical for this finding since it
allowed us to assess the individual effects of two
processes—the knocking out of MAM1 and the
overexpression of MAM3—that are difficult to
separate experimentally.
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In modern quantitative biochemistry, the combination
of experimental and computational approaches is
becoming more and more important (cf. Heinrich and
Schuster 1996; Fell 1997; Fong and Palsson 2004). It
is a trademark of modern systems biology (cf. Klipp
et al. 2005) that experiment and modeling are
combined in a synergistic way. Due to the complexity
of most metabolic networks, understanding their
behavior intuitively is next to impossible, all the
more when multifunctional enzymes are involved.
Approaches have been developed using kinetic
models involving differential equations, with each
differential equation describing the rate of change in
one metabolite concentration. The temporal changes
of metabolite concentrations are calculated by numer-
ical integration of their differential equations. At
steady state, the metabolite concentrations do not
change anymore, and so the differential equations can
be set equal to zero and, therefore, simplified to give
algebraic equations. In a reaction network at steady
state, the participating enzymes exert a certain
amount of control over the magnitudes of the
metabolic fluxes and the levels of the metabolites in
the system. The quantification of this control for each
enzyme in the network in steady state can be
expressed in control coefficients. Those coefficients
were defined within the theory of Metabolic Control
Analysis, which was developed by Kacser and Burns
(1973) and Heinrich and Rapoport (1973, 1974) (cf.
Heinrich and Schuster 1996). Control coefficients are
systemic properties, which are influenced by network
structure, the kinetic parameters of enzymes and the
equilibrium constants of reactions.
Plant metabolism has repeatedly been the subject of
kinetic modeling, for reviews see Morgan and Rhodes
(2002) and Lange (2006). Here, we present a kinetic
model of the synthesis of aliphatic glucosinolates in
Arabidopsis thaliana leaves (in particular, its Colum-
bia ecotype). Glucosinolates, the subject of this special
issue, are one of the largest groups of secondary
metabolites in A. thaliana (Halkier and Gershenzon
2006; Grubb and Abel 2006) and serve as anti-
herbivore defenses (Wittstock et al. 2003). These
amino acid-derived substances have variable side
chains and are linked to a glucose residue (Fahey et al.
2001) (Fig. 1). Besides variation in chain length,
different precursor amino acids and diverse patterns
of secondary oxidation and esterification contribute to
the diversity of glucosinolates (Tokuhisa et al. 2004;
Kliebenstein, this issue). The largest group of gluco-
sinolates in A. thaliana is biosynthesized from
methionine, which is initially transaminated to a
2-oxo-acid. Subsequently, the 2-oxo-acid is subject
to repeated chain elongation, followed by the forma-
tion of the glucosinolate core and side chain
modifications (Wittstock and Halkier 2002). Chain
elongation is the first phase of glucosinolate formation
and is thus responsible for redirecting the amino acid
flux from primary to secondary metabolism.
Glucosinolates of six different chain lengths,
referred to as a C3 to C8 glucosinolates, are produced
in A. thaliana, due to a variable number of iterative
chain elongation cycles, each adding one methylene
carbon to the molecule (Graser et al. 2000). In the
Columbia ecotype, the first reaction of the three-step
chain elongation cycle, the condensation of a 2-oxo
acid with acetyl-CoA, is catalyzed by one of two
methylthioalkylmalate synthase enzymes: MAM1
and MAM-L. MAM1 acts principally on the 2-oxo-
acids with the two shortest chain lengths and with a
very weak activity on the third one (Textor et al.
2004; Benderoth et al. 2006), while MAM-L acts on
all six 2-oxo-acids present (Textor et al. 2007).
Textor et al. (2007) proposed renaming MAM-L as
MAM3, based on the biochemical properties of the
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encoded enzyme and the earlier naming of MAM1
and MAM2 (Kroymann et al. 2003). For a detailed
discussion on the evolution of the genes encoding the
MAM enzymes, please see Benderoth et al., this
issue. The MAM synthases belong to a large enzyme
family condensing various 2-oxo acids with an acyl-
CoA ester (Textor et al. 2004). The broad substrate
specificity of MAM3 and the fact that the kinetic
parameters for substrates of varying chain length
form a non-monotonic series (see Table III in Textor
et al. 2007) raised the question of how these prop-
erties contribute to the complex glucosinolate
distribution and their changes observed in vivo.
Unfortunately, the nonlinearity of Michaelis-Menten
kinetics and the convoluted structure of the biosyn-
thetic network make the system so complex that
intuitive reasoning is insufficient to explain the
observed profiles.
The chain-length spectrum of aliphatic glucosin-
olates in A. thaliana is critically influenced by
metabolic partitioning at the branchpoint between
diversion into glucosinolate core biosynthesis or
further elongation. The first step after the branchpoint
in further elongation is an irreversible reaction
catalyzed by the methylthioalkylmalate (MAM) syn-
thases. These likely exert flux control. The first step
in the diversion is a transamination which is fast and
reversible. As fast, reversible reactions exert virtually
no control on metabolic flux (cf. Heinrich and
Schuster 1996; Kholodenko et al. 1998), the relevant
step for understanding control at this branchpoint is
the second reaction, the conversion of the elongated
amino acid to an oxime, catalyzed by CYP79F1 (for
all chain lengths) and CYP79F2 (for the two longest
chains). The latter two enzymes are again likely to
exert flux control.
Despite knowledge of the substrate kinetics of the
chain elongation cycle enzymes MAM1 and MAM3,
mutations in the corresponding genes lead to gluco-
sinolate profiles differing from those of wild-type
plants that are not fully explainable: MAM3 missense
or knockout mutants show almost no change in C3
glucosinolates and only a slight increase in C4, but
have a complete lack or much reduced level of long-
chain glucosinolates C6–C8, which can be restored by
transgenic expression of MAM3 (Field et al. 2004;
Textor et al. 2007). MAM1 mutants also show an
interesting glucosinolate profile: whereas C4 gluco-
sinolates are dominant in wild-type plants, in MAM1
missense or knockout mutants C3 glucosinolates are
more abundant (Haughn et al. 1991; Kroymann et al.
2001; Textor et al. 2007). The glucosinolate profile of
a plant line in which the MAM1 gene is disrupted by a
T-DNA insertion (gsm1-3) was examined by Textor
et al. (2007). In addition to a large reduction in C4
and a concomitant increase in C3 glucosinolates, it
shows two other differences in comparison to the
wild-type (Fig. 3a): a moderate increase in C8
glucosinolates and an increase in total aliphatic
glucosinolates. To elucidate the mechanisms leading
Fig. 1 The pathway of
methionine-derived
glucosinolate biosynthesis
in A. thaliana can be
divided into the methionine
chain elongation cycle and






intermediates are shown in
the form of substance
classes of different chain
lengths. For A. thaliana, n
ranges from 1 to 6
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to these changes in the glucosinolate profile was
another motivation for constructing a mathematical
model.
The model uses pathway architecture and exper-
imentally determined enzyme kinetic data to evaluate
the contribution of MAM1 and MAM3 to the
glucosinolate profile and to determine how the
properties of both enzymes affect the diversity of
aliphatic glucosinolate chain lengths in A. thaliana
leaves. To test the reliability of our model, we
conducted a simulation not only for the Columbia
wild type, but also for the MAM1 mutant gsm1-3 and
the MAM3 missense mutant gsm2-1 (Textor et al.
2007). When kinetic data were not known, we chose
values to make the agreement of the model predic-
tions with the actual distribution of different chain-
length glucosinolates as good as possible. Due to the
uncertainty of these parameters, the model is not an
exact quantitative simulation, but attempts to explain




Figure 1 depicts a cyclic architecture for the gluco-
sinolate chain elongation pathway. However, while
elongation is cyclic from the point of view of the
enzymes, it is not from the viewpoint of the
metabolites since the product of the ‘‘cycle’’ is not
identical to the starting substrate, but involves an
additional methylene group. Thus in this model we
depict the pathway as a branched acyclic network
(Fig. 2) to accurately assess the concentration profile
of the different metabolites.
To reduce the complexity of the model, most of the
enzymes of the pathway are not considered separately.
Such ‘‘skeleton models’’ consisting of few overall
reactions have turned out to be very useful in previous
studies (cf. Selkov 1975; Heinrich and Schuster 1996).
The first transamination of methionine leading to its 2-
oxo-acid MTOB (see list of abbreviations) was left out
as transamination reactions are usually fast and
reversible and so can be regarded to be in rapid
equilibrium. Therefore, the concentration of MTOB is
assumed to be in equilibrium with methionine, and
MTOB was considered as the initial substrate with a
constant concentration (designated as an external
metabolite for purposes of the model). The same
reasoning applies to the transamination reactions
converting the chain-elongated 2-oxo-acids to the
elongated homomethionine derivatives which are also
assumed to be in quasi-equilibrium.
Some more simplifications can be achieved by
applying the principles of Metabolic Control Analysis
(cf. Heinrich and Schuster 1996), applicable whenever
the system is at steady state. Important in this respect
are particularly the structure of the network, e.g. the
branching pattern, and the reversibility or irreversibil-
ity of the catalyzed reactions. If we assume a buffered
concentration of the substrate pool for a reaction
network branch, the enzyme catalyzing the first
irreversible reaction exerts full control over the
magnitude of the metabolic flux in that branch if there
is no feedback from downstream intermediates or
signaling to that enzyme (Heinrich and Rapoport 1974,
cf. Heinrich and Schuster 1996). Then all subsequent
enzymes can be considered to exert virtually no control
over flux, so that the branch is effectively ‘‘shortened’’.
In glucosinolate chain elongation, the condensa-
tion reactions catalyzed by MAM1 and MAM3 are
irreversible because they involve hydrolysis of the
high energy thioester bond of an acetyl-CoA (Textor
et al. 2004, 2007). Following the ‘‘skeleton model’’
approach, we have neglected the other two steps of
the chain elongation cycle, isomerization and oxida-
tive decarboxylation, in our kinetic modeling. These
are incorporated into the condensation reactions, thus
reducing complexity and parameter number. This
simplification is justified by the fact that the MAM1
and MAM3 reactions are the first irreversible reac-
tions in the pathway, so that they fully control the
overall metabolic flux through glucosinolate biosyn-
thesis, if we assume a constant concentration of
methionine. A further reason for the lack of control at
the isomerization step is that isomerization reactions
are nearly always fast because they are monomolec-
ular. The three reaction chain-elongation sequence
was therefore represented by the condensation reac-
tion catalyzed by the MAM enzymes, which was
denoted by Ei (Fig. 2), with i standing for the index of
the elongation step. Whereas the enzyme catalysing
the first irreversible reaction determines the magni-
tude of the overall flux through a branched pathway,
downstream enzymes can control the distribution of
this flux through diverging sub-branches.
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Similar reasoning was applied for the sub branch
of glucosinolate core formation: The CYP79F1 and
F2 monooxygenases catalyze the formation of an
aldoxime from homomethionine in an oxidative
decarboxylation, which can be considered nearly
irreversible because of the formation of (gaseous)
CO2 and the consumption of oxygen. Therefore, we
neglect the enzymes downstream of CYP79F1 and
F2, as they likely exert almost no control on the flux
distribution into their sub-branch. The six different
reactions of core glucosinolate formation catalysed
by CYP79F1 (two of which are also catalysed by
CYP79F2) are here denoted as G1–G6: They include,
moreover, the reamination reactions, which are in
quasi-equilibrium.
An interesting point is how control is distributed at
the branch points in the network (see Fig. 2). Control
over the total flux is almost entirely exerted by the
MAM enzymes upstream of the first branch point. By









elongation process as a
series of sequential events.
Simplification was achieved
by reducing each chain
elongation cycle into one
step, Ei, and reducing the
conversion of chain
elongated 2-oxo acids
(MTOP, MTOH…) into the
final glucosinolates (C3,
C4…) into one step, Gi, as




into the first condensation
step. To reach a steady state
level of glucosinolates, a
hypothetical degradation
step was included. For
abbreviations, see text
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and the CYP79F1 and F2 enzymes exert control over
the flux ratios between further elongation and diver-
sion into glucosinolate core biosynthesis.
In addition to the formation of the different chain-
length glucosinolates, degradation reactions were
included in the model in order to endow the glucosin-
olate products with a stationary state. Without the
inclusion of such degradation reactions, which may
also be considered to represent dilution by cell growth,
the glucosinolates would permanently accumulate in
the model making the calculations more cumbersome.
Rate laws and kinetic parameters
The condensation reactions Ei, leading to chain-
elongated 2-oxo acids, and the reactions from the
chain-elongated homomethionines to the final gluco-
sinolates were modeled by irreversible Michaelis-
Menten rate laws (which have been measured for
MAM3 and assumed for MAM1, CYP79F1 and F2),
v ¼ Vmax  S
Km þ S : ð1Þ
As the transamination reactions between these two
steps were considered to be in quasi-equilibrium, their
equilibrium constants were combined with the follow-
ing glucosinolate-formation steps in one reaction.
Quasi-equilibrium implies that we can use the mass-
action law:
P ¼ q  T ð2Þ
with q being the equilibrium constant and P and T
denoting the concentrations of extended analogs of
methionine and MTOP or its extended analogs,
respectively. This can be inserted into Eq. 1 with S
replaced by P:
v ¼ Vmax  q  T





Reaction velocities and concentrations of T are
calculated automatically during time course and
steady state calculation.
A serious problem is that the maximal velocities,
Vmax, are unknown because they are proportional to the
enzyme concentrations. We circumvented this prob-
lem by making use of the fact that most of the enzymes
involved in this network are multifunctional so that the
enzyme concentration is the same for each particular
reaction catalysed by the same enzyme. Moreover, it
should be noted that scaling all reaction rates in a
metabolic network by the same factor leaves all steady-
state metabolite concentrations unchanged (cf.
Heinrich and Schuster 1996; Fell 1997). Instead of
Vmax values for MAM3, we started from the values that
are usually measured in experiment—the turnover
numbers normalized by the molar mass of the enzyme,
that is, the maximal velocity normalized by mass
concentration of the enzyme (Table III in Textor et al.
2007). As the mass concentration of MAM3 is
unknown, we rescaled all experimentally measured,
normalized maximal velocities, such that the virtual
mass concentration of MAM3 in the wild-type is
1 lg l-1. This choice is equivalent to a scaling by the
unknown mass concentration of MAM3. Practically,
this meant that we multiplied the measured values in
the enzyme assay of nmol min-1 mg-1 by a MAM3
concentration of 1 lg l-1 and changed the unit into
nmol min-1 l-1. This rescaled normalized Vmax is here
denoted by V 0max: Explaining this rescaling in another
way, it can be said that from the measured activities of
MAM3, we can see the relative activities of that
enzyme on the various chains lengths rather than the
absolute Vmax values. Nevertheless, this is sufficient for
calculating the relative glucosinolate chain-length
distributions. Since, in the model, we need to take
some absolute values of kinetic parameter values, we
did the rescaling explained above, keeping in mind that
only relative values are known. Another variant would
be to keep the turnover numbers normalized by the
molar mass as they have been measured and scale the
maximal velocities and rate constants of all the other
reactions accordingly. However, we believe it is easier
to think in terms of maximal velocities, even if they are
based on assumed enzyme concentrations.
The maximal velocities of MAM1, CYP79F1 and
CYP79F2 and the rate constants of the degradation of
glucosinolates are fitted rather than measured, so that
we can decide to fit them as scaled values. However,
in the MAM1 knockout mutant, to be discussed
below, the concentration of MAM3 differs from that
in the wild-type by a factor x to be determined later.
Thus, the observed difference in the transcript levels
is translated into a difference in the enzyme concen-
tration and, thus, in V 0max: In this case, V
0
max of MAM3
from the wild type is scaled to correspond to a mass
concentration of x lg l-1. In light of the way the
model is constructed, we cannot directly compare the
absolute contents of glucosinolates per gram dry
44 Phytochem Rev (2009) 8:39–51
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weight with those present in the plant. However, we
can compare the relative distributions, and likewise
the change of distribution between wild-type and
mutant lines.
Table 1 shows the kinetic parameters and the
initial (fixed) concentration of MTOB used in the rate
laws. Kinetic values set in Roman type were obtained
from Textor et al. (2004, 2007), or, in the case of the
CYP79F1/F2 enzymes, from Chen et al. (2003).
Values set in italics were derived from assumptions
given above or chosen from preliminary simulations
to optimize correspondence of the model with actual
glucosinolate chain-length distributions observed.
Kinetic values for some reactions were not consid-
ered in the model. Branched-chain Aminotransferase
4, which has been shown to catalyze the transamination
of methionine to MTOB follows a reversible Michae-
lis-Menten kinetics (Schuster et al. 2006a, b), and both
Vmax and Km values were reported. However, since
there are six further transamination reactions, an
inclusion of these measured values in the model would
mean having to represent the following six
Table 1 Overview of data used in constructing the mathematical model (see also Fig. 2)a
Step Reaction Kinetics Equilibrium constant
q (no unit), mass action
rate constant k (min-1)






E1 (MAM3) MTOB ? MTOP Irreversible
Michaelis-Menten
932 17.38 1.448
E2 (MAM3) MTOP ? MTOH 476 17.94 1.495
E3 (MAM3) MTOH ? MTOHp 463 34.43 2.869
E4 (MAM3) MTOHp ? MTOO 358 16.8 1.4
E5 (MAM3) MTOO ? MTON 253 4.37 0.364
E6 (MAM3) MTON ? MTOD 81 0.37 0.031
E1 (MAM1) MTOB ? MTOP 3,000 0 45
E2 (MAM1) MTOP ? MTOH 640 0 100
G1 (Cyp79F1) MTOP ? C3 v ¼ Vmax  TKM
q þT
q = 4 34 0.46
G2 (Cyp79F1) MTOH ? C4 q = 1 34 1
G3 (Cyp79F1) MTOHp ? C5 q = 1 37 0.024
G4 (Cyp79F1) MTOO ? C6 q = 1 194 0.04
G5 (Cyp79F1) MTON ? C7 q = 1 216 0.016
G6 (Cyp79F1) MTOD ? C8 q = 1 74 0.008
G5 (Cyp79F2) MTON ? C7 q = 1 374 0.01
G6 (Cyp79F2) MTOD ? C8 q = 1 26 0.01
Degradation
C3 ? Irreversible mass action k = 7 * 10-7
C4 ? k = 7 * 10-7
C5 ? k = 7 * 10-7
C6 ? k = 7 * 10-7
C7 ? k = 7 * 10-7
C8 ? k = 7 * 10-7
a Parameters given in roman are experimental kinetic data, while those written in italics have been optimized to fit the model.
Experimental data for MAM3 was obtained in Textor et al. (2007); for MAM1 in Textor et al. (2004) and for Cyp79F1 and F2 in
Chen et al. (2003). Constant concentration of the external metabolite OMTB = 1 lM
E1-E6: Chain elongation of the 2-oxo acids, represented by the condensation reaction catalyzed by MAM1 and MAM3
G1-G6: Core glucosinolate formation and reamination (equilibrium), represented by the aldoxime formation catalyzed by Cyp79F1
and F2
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transamination reactions (which are not yet character-
ized) by unknown parameters, increasing
computational difficulties. As transamination reac-
tions are known to be fast and reversible (as discussed
above), we can assume that the Vmax values of the
uncharacterized transamination reactions of the chain-
elongated 2-oxo-acids are in all probability large
enough to allow the reactions to be fast and in rapid
equilibrium. This reduces the number of unknown
parameters significantly to one unknown parameter per
reaction, the equilibrium constant q. Since values for
the equilibrium constants of the specific transaminase
reactions involved in glucosinolate biosynthesis are
not available, we used a value of 4 for the transami-
nation of the first chain-elongated 2-oxo-acid (MTOP)
and a value of 1 for all further transaminations, since
these optimized the model best with the actual
glucosinolate distribution and are in the range of
equilibrium constants of other transaminase reactions
reported in the literature (Tachiki and Tochikura 1975;
Cruickshank and Isherwood 1958). A similar reason-
ing underlies the choice of V 0max for the steps from
transamination to glucosinolate formation. To simplify
the model, the very weak activity of MAM1 on MTOH
was left out.
For the degradation reactions, simple irreversible
mass action kinetics were assumed v ¼ k  S (S: C3,
C4,…; v: reaction rate; k: rate constant). All the rate
constants were assigned the same value regardless of
chain length.
To model the MAM1 and MAM3 knockout mutant,
we set the maximal velocities of their catalyzed
reactions to zero. For the MAM1 mutant, we assumed
a compensatory overexpression of MAM3. We mod-
elled this by a 12-fold increase of the maximal
activity of all MAM3 reactions, again with zero
activity of MAM1.
Metabolite concentrations
The concentrations of the chain-elongated 2-oxo
acids and the final glucosinolates were allowed to
vary in the model and are calculated under steady-
state conditions from the system equations. Their
initial concentrations were set to zero. All other
metabolites, in particular the initial substrate for
chain elongation, MTOB, were regarded as ‘‘external
metabolites’’ and assumed to have fixed concentra-
tions. Note that not all of these metabolites
(e.g. acetyl-CoA and the amino group donor of the
transaminase) are explicitly given.
Concentrations refer to total cell volume rather
than particular organelles, although glucosinolates
appear to be synthesized in the chloroplasts and
cytosol and stored in vacuoles. This is because the
measurements were done for entire tissues rather than
particular organelles. Thus, concentrations should
here be interpreted as average values.
Software
Numerical calculation employed the metabolic sim-
ulation package COPASI (Hoops et al. 2006), which
is freely available from http://www.copasi.org. Here
the input reaction kinetics and the reaction network
structure are translated automatically into ordinary
differential equations.
Results
When the simulated glucosinolate distribution for the
wild type Columbia computed by the model is
compared to the actual glucosinolate content of this
plant line measured by chemical analysis, the profiles
are shown to be in good agreement with each other
(Fig. 3). For the MAM1 knockout mutant, two
simulations were carried out: In the first simulation,
the maximal velocities of MAM1—catalyzed reac-
tions were set to zero and the same MAM3 activity as
in the wild type model was used (Fig. 3b). This
resulted in the reversal of the ratio of C3/C4
glucosinolates as seen in the actual glucosinolate
content of the MAM1 mutant. However, it led to a
depletion of the C8 glucosinolates and, furthermore,
to a significant reduction of the total glucosinolate
content. Neither of the two latter effects is in
accordance with the experimental data, which indi-
cate a significant increase in C8 content, together with
a moderate increase in total glucosinolate content. A
decrease in the activity of an enzyme such as MAM1
should lead to a decrease in the steady-state concen-
trations of all metabolites downstream of the
perturbed enzyme according to Metabolic Control
Analysis (cf. Heinrich and Schuster 1996; Fell 1997),
unless the pathway has unusual kinetic properties
such as substrate inhibition. However, the deficiency
of an enzyme in a mutant is often at least partially
46 Phytochem Rev (2009) 8:39–51
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compensated by an increase in the activity of other
enzymes (e.g. Fong and Palsson 2004). This has
indeed been found for MAM1 deficiency based on the
elevated transcript level of MAM3 in the MAM1
mutant (Textor et al. 2007, see supplemental Fig. 3).
Therefore, in our second simulation, it was assumed
that the loss of MAM1 is compensated by an
overexpression of MAM3. With a 12-fold increase
of the maximal activity of all MAM3 reactions, the
predicted glucosinolate profile is now similar to the
actual profile measured by direct chemical analyses.
All of the three observations mentioned in the
Introduction (significant increase in C8 glucosino-
lates, moderate increase of total glucosinolate content
and reversal of the C3/C4 ratio) are reproduced in this
simulation, and thus can be explained by a knockout
of MAM1 with a compensatory overexpression of
MAM3. This qualitative effect is largely independent
of the exact Km values of MAM3, as was checked by
simulations (data not shown).
Two MAM3 mutant lines, gsm2-1 (a missense
mutant) and gsm2-2 (a T-DNA insertion line) show a
slight increase in the proportion of C4 glucosinolates
and a depletion of the longest chain glucosinolates,
C7 (in gsm2-1) and C8 (in both mutants) (see Textor
et al. 2007 and Fig. 3a). A simulation of a MAM3
knockout mutant, in which the maximal velocities of
MAM3—catalyzed reactions were set to zero
(Fig. 3b), reflected these profile changes well. The
model of the MAM3 knockout mutant also showed
proportions of zero for the C5 and C6 glucosinolates,
while minor amounts of these compounds were
observed in the actual plant analyses.
Discussion
The aliphatic glucosinolates in A. thaliana are a large
group of methionine-derived secondary metabolites.
Their structural diversity arises in large part from the
variable length of their side chains. The corresponding
metabolic network is so complex that mathematical
modeling is required to try to understand it. Here, we
have established a model of the biosynthesis of the
aliphatic glucosinolates in A. thaliana, based on our
knowledge of the structure of the pathway, the kinetic
properties of its enzymes and MAM transcript levels.
Given the cyclic nature of the pathway, the irregular
variation in kinetic parameters for substrates of varying
chain length and the involvement of two MAM
enzymes, it was impossible to judge how alterations
in kinetic parameters would affect the product outcome
by simple inspection. Mathematical modeling provides
a powerful tool to increase our understanding of
metabolic networks in living cells (Heinrich and
Schuster 1996; Mendes 1997). A particular challenge
Fig. 3 Comparison of actual leaf glucosinolate profiles of
plant lines to those predicted by the mathematical simulation.
(a) Actual values measured from analyses of leaves of the Col-
0 wild-type (white bars), of the MAM1 knockout mutant gsm1-
3 (grey bars) and the MAM3 knockout mutant gsm2-1 (grid
bars). Aliphatic glucosinolates sum up to 22.4 (wild type), 27.3
(MAM1 knockout mutant) and 21.5 (MAM3 knockout mutant)
lmol * gDW-1. C7 and C8 glucosinolates were not detected in
the MAM3 knockout mutant gsm2-1. Glucosinolates were
isolated, identified and quantified as described in Textor et al.
(2007). Mean and standard error are based on three replicate
samples. Where standard error was not depicted, it was too
small to show accurately. (b) Modelled glucosinolate profile.
Wild-type (white bars), MAM1 knock-out mutant with (grey
bars) and without (black bars) compensation for MAM3
overexpression and MAM3 knockout mutant (grid bars)
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in constructing this model was dealing with enzymes
having broad substrate specificities. This is a hallmark
of many enzymes of secondary metabolism and
contributes to the enormous diversity of products
observed (e.g., Gang et al. 2002). Only a few modeling
studies on such enzymes have been presented so far
(Kacser and Beeby 1984; Nun˜o et al. 1997; Schuster
and Zevedei-Oancea 2002, 2004).
Although we constructed a simplified, ‘‘skeleton’’
model, less than half of the necessary parameters were
available or could be derived from the literature. We
chose the remaining parameter values such that the
model predictions for the Columbia wild-type were in
good agreement with the actual glucosinolate profiles
analyzed. Also the model predictions for MAM1 and
MAM3 knockout mutants showed a striking agreement
with the actual glucosinolate content of the respective
plant lines, given the degree to which the pathway of
aliphatic glucosinolate biosynthesis was simplified for
modeling purposes. The simulated glucosinolate pro-
files show qualitatively and semi-quantitatively all the
same important characteristics as the actual profiles
(see Results section).
The change in glucosinolate profile of the MAM1
mutant relative to wild-type is due to the remaining
MAM3 activity. The MAM1 mutant exhibits a leaf
glucosinolate profile involving all chain lengths C3–
C8 dominated by C3 and C8. Although a trace level of
MAM1 transcript is detectable in this mutant (see
Textor et al. 2007; supplemental Fig. 3), the near
identity of this glucosinolate phenotype with that
previously described for a MAM1 missense mutant
(gsm1-1, Kroymann et al. 2001) suggests that it is a
virtual knock-out. The MAM3 mutant was simulated
as a total knockout, lacking C5–C8 glucosinolates, but
small amounts of these compounds are found on
actual analyses. Much of the observed C5 glucosin-
olate content likely results from the weak activity of
MAM1 for the third elongation reaction, which was
omitted from the model for simplicity reasons. The
small amounts of the longer aliphatic glucosinolates,
C6–C8, for the two MAM3 mutants gsm2-1 and gsm2-2
might be due to a residual activity of MAM3.
Using the model, we were able to substantiate
experimental indications that the levels of the two
MAM activities are dependent on each other, as the
loss of MAM1 is accompanied by a compensatory
increase of MAM3. The final glucosinolate profile is
thereby strongly determined by the ratio of MAM1 and
MAM3 catalytic activities on a common pool of
methionine or its 2-oxo acid derivatives, suggesting
that the two enzymes are located in the same subcel-
lular compartment. Since MAM1 is predicted to be a
plastidial protein and MAM3 has been proven to be so
(Textor et al. 2007) this common compartment is most
likely the chloroplast. Moreover, the model calcula-
tions showed that the reversal in the C3/C4 ratio is
mainly due to the loss of MAM1 activity, while the
increase in the C8 share and the total glucosinolate
content in the MAM1 knock-out mutant is due to
elevated levels of MAM3. As mentioned in the Results
section, an increased transcript level of MAM3 in the
MAM1 mutant was observed experimentally. This can
be understood intuitively: the plant ‘‘attempts to’’
compensate for the loss of MAM1 by elevating the
level of the other condensing enzyme. An open
question is how this over-expression of MAM3 is
facilitated at the level of the gene-regulation network.
The computer simulation showed that a MAM1 mutant
without increased MAM3 activity would suffer a
decrease in both the proportion of C8 glucosinolates
and in total glucosinolate content, in contrast to the
actual plant analyses. Thus, the model turned out to be
valuable in explaining the role of compensatory MAM3
expression by allowing one to separate two pro-
cesses—knockout of MAM1 and compensation by
MAM3. These two events occur together in reality and
are thus difficult to separate experimentally. Compar-
ing the MAM1 knockout mutant without
overexpression of MAM3 with the MAM3 knockout
mutant shows that the MAM3 activity leads to a
dominance of C3 in the glucosinolate profile, while the
MAM1 activity leads to an abundance of C4.
The kinetic parameters employed in the model
were measured in vitro as is typically done in
metabolic modeling studies (e.g. Heinrich et al.
1977; Galazzo and Bailey 1990; Heinrich and
Schuster 1996; Chassagnole et al. 2001). Accurate
in vivo kinetic data for glucosinolate biosynthetic
enzymes are virtually impossible to obtain in our
present state of knowledge because measurement
would need to be restricted to only those cells
involved in glucosinolate production. In constructing
our model, missing parameter values were estimated
so as to optimize the agreement between the model
and the system under investigation, as has also been
done in many classical metabolic modeling studies.
While there are often discrepancies between enzyme
48 Phytochem Rev (2009) 8:39–51
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properties in vitro and in vivo (Benevolensky et al.
1994), the good agreement of the model with
measured glucosinolate concentrations in wild-type
and two different mutant situations suggests that in
vitro kinetic data are a good approximation of in vivo
enzyme behavior in this case.
Due to the gaps in our knowledge of the kinetic
parameters of glucosinolate biosynthetic enzymes,
we abstained from building a comprehensive kinetic
model aimed at an exact quantitative simulation. Our
model is nevertheless ideal for answering questions
such as: Which factors lead to the three concomitant
changes in glucosinolate profile observed between the
wild type and MAM1 knockout mutant? Can the
counter-intuitive increase in total glucosinolate con-
tent be simulated by what is known about the
structure and parameters of the biochemical network?
The model presented here should nevertheless be
considered as a first step towards a more quantitative
description of glucosinolate biosynthesis. As more
experimental data become available, they will be
included in future versions of the current model. It
will then be important to test the reliability of the
model by applying it to more variants or even
different individual plants.
A further direction in which such metabolic
models can be refined comes from the fact that
the total enzyme concentration of a multifunctional
enzyme (with broad substrate specificity) is actually
distributed over the different substrates. In the case
under study, the 2-oxo-acids of different chain
length may compete among each other for the
MAM enzyme. Therefore, the magnitude of meta-
bolic flux, which is determined by the amount of
MTOB catalyzed, may be diminished by the
proportion of MAM1 and MAM3 involved in the
catalysis of other chain length 2-oxo-acids. Strictly
speaking, this would require deriving a more
complicated enzyme kinetics because the usual
Michaelis-Menten kinetics is based on the conser-
vation relation E þ ES ¼ const:; while an enzyme
with broad substrate specificity implies a more
complicated conservation relation. This leads to an
effective decrease of the enzyme amount available
for each particular substrate. We can assume,
however, that we have partially circumvented this
problem here by the use of scaled maximal veloc-
ities (V 0maxÞ:
One parameter that obviously differs between the
in vivo and in vitro situations is temperature. As
plants live under varying temperatures, it is hard to
decide which temperature should be used for in vitro
measurements. In a classical approach, this is done
under conditions where enzyme activity is highest,
which turned out to be 32C for MAM3 in our system
(Textor et al. 2007). Since a change in temperature
affects most enzyme activities in a similar way,
stationary metabolite levels would not be expected to
change dramatically when all enzyme activities were
subjected to a similar temperature change. This is
mathematically expressed by the summation theorem
for concentration control coefficients (cf. Heinrich
and Schuster 1996; Fell 1997). A similar reasoning
applies to changes in the pH value.
An important goal of mathematical modeling in
cell biology is to derive theoretical predictions that
can be verified later in experiments. However, the
predictive power of theoretical biology is much more
limited than that of theoretical physics so far,
although some success stories exist (cf. Schuster
et al. 2006a, b). Nevertheless, modeling is useful also
in other ways. Mathematical models allow for a
formalization and validation or falsification of
hypotheses. A model allows integration of diverse
experimental data and information to reveal regula-
tory properties of cellular networks. It helps us to
better understand the role of underlying mechanisms.
In the system studied here, the model showed that the
overexpression of MAM3 in compensation for the
knock-out mutation of MAM1 is crucial to the
resulting glucosinolate profile and the increase in
total glucosinolate content. Even though the simula-
tion did not provide exact numbers for these effects,
numerical calculations allowed us to argue in more
concrete terms than would have been possible by
purely intuitive reasoning.
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